Caryn Lerman

Dr. Caryn Lerman is the Director of the USC Norris Comprehensive Cancer Center, Associate Dean for Cancer Programs, and the H. Leslie and Elaine S. Hoffman Cancer Research Chair at the Keck School of Medicine of USC. She is recognized for her cancer prevention research that bridges the fields of neuroscience, genomics, pharmacology, and population science. A major unifying focus of her research is biology-driven science to reduce cancer risk behaviors. This work has spawned novel lines of investigation, including: the behavioral epidemiology of cancer genetic susceptibility testing; pharmacogenomic approaches to tobacco dependence leading to the first prospective stratified pharmacogenomic trial in this area; and neuroscience-based interventions to reduce tobacco dependence. Her current research focus is on the therapeutic potential of psilocybin and other psychedelic therapies.

An elected member of the National Academy of Medicine, Dr. Lerman has served as a member of the NCI Board of Scientific Advisors, the National Human Genome Research Advisory Council, and the National Institutes on Drug Abuse Advisory Council. She is the current Vice President/President-Elect of the Association of American Cancer Institutes and a past president of the Society for Research on Nicotine and Tobacco. Additional awards and honors include the American Cancer Society Cancer Control Award, the American Society of Preventive Oncology Joseph Cullen Award, the Alton Ochsner Award Relating Smoking and Health, the NIH Matilda White Riley Award, and the Los Angeles Business Journal award for Women Leaders in Healthcare.

Prior to her appointment as Director of the USC Norris Comprehensive Cancer Center, Associate Dean for Cancer Programs, and H. Leslie and Elaine S. Hoffman Cancer Research Chair at USC’s Keck School of Medicine, Dr. Lerman served as Senior Deputy Director of the Abramson Cancer Center and Vice Dean for Strategic Initiatives in the Perelman School of Medicine at the University of Pennsylvania.

• Title(s)Distinguished Professor of Psychiatry and the Behavioral Sciences and PsychologySchoolKeck School of Medicine of UscPhone+1 323 865 0816vCardDownload vCard: Download vCard, Title(s)Distinguished Professor of Psychiatry and the Behavioral Sciences and PsychologySchoolKeck School of Medicine of UscPhone+1 323 865 0816vCardDownload vCard Title(s)Distinguished Professor of Psychiatry and the Behavioral Sciences and PsychologySchoolKeck School of Medicine of UscPhone+1 323 865 0816vCardDownload vCard +1 323 865 0816
• Title(s)Distinguished Professor of Psychiatry and the Behavioral Sciences and PsychologySchoolKeck School of Medicine of UscPhone+1 323 865 0816vCardDownload vCard: Download vCard, Title(s)Distinguished Professor of Psychiatry and the Behavioral Sciences and PsychologySchoolKeck School of Medicine of UscPhone+1 323 865 0816vCardDownload vCard +1 323 865 0816

• USC Tobacco Center of Regulatory Science
  NCI · Sep 1, 2023 – Aug 31, 2028 · Role: Co-Investigator
• Neural basis of smoking relapse
  NIH · R01DA041402 · Apr 1, 2016 – Jan 31, 2021 · Role: Principal Investigator
• Neuroscience-based Interventions for Cancer Risk Behavior Change
  NIH · R35CA197461 · Aug 1, 2015 – Jul 31, 2022 · Role: Principal Investigator
• USC Tobacco Center of Regulatory Science
  NIH · U54CA180905 · Sep 19, 2013 – Aug 31, 2028 · Role: Co-Principal Investigator
• UPENN TCORS: Tobacco Product Messaging in a Complex Communication Environment
  NIH · P50CA179546 · Sep 18, 2013 – Aug 31, 2019 · Role: Co-Principal Investigator
• Retraining Neurocognitive Mechanisms of Cancer Risk Behavior (PQ4)
  NIH · R01CA170297 · Sep 1, 2012 – Jun 30, 2018 · Role: Principal Investigator
• Cognitive Training for Nicotine Dependence
  NIH · R01DA030819 · Sep 30, 2010 – Jun 30, 2016 · Role: Principal Investigator
• Abramson Cancer Center Support Grant
  NIH · P30CA147859 · Sep 30, 2009 – Sep 29, 2012 · Role: Principal Investigator
• Functional Characterization of OPRM1 A118G in Nicotine Dependence
  NIH · R21DA027066 · Sep 30, 2009 – Aug 31, 2011 · Role: Co-Principal Investigator
• Nicotine Abstinence-Induced Cognitive Alterations by COMT Genotype
  NIH · R03DA027438 · Sep 15, 2009 – Aug 31, 2012 · Role: Principal Investigator
• Center for Interdisciplinary Research on Nicotine Addiction (CIRNA)
  NIH · P50CA143187 · Aug 1, 2009 – Jul 31, 2015 · Role: Principal Investigator
• Neural Substrates of Cognitive Deficits in Nicotine Withdrawal
  NIH · R01DA026849 · Aug 1, 2009 – May 31, 2013 · Role: Principal Investigator
• Pharmacogenetics of Nicotine Addiction Treatment
  NIH · U01DA020830 · Sep 15, 2005 – Jun 30, 2016 · Role: Principal Investigator
• Pharmacogenetic Investigation of Naltrexone
  NIH · R01DA017555 · Sep 30, 2003 – Jun 30, 2009 · Role: Principal Investigator
• Transdisciplinary Tobacco Use Research Centers
  NIH · P50CA084718 · Sep 30, 1999 – Sep 29, 2009 · Role: Principal Investigator
• CANCER GENETICS NETWORK
  NIH · U24CA078146 · Aug 1, 1998 – Sep 30, 2007 · Role: Co-Principal Investigator
• Decisions &Outcomes of BRCA1/2 Test for Breast Patients
  NIH · R01CA074861 · Aug 1, 1997 – Jun 30, 2010 · Role: Co-Principal Investigator
• University of Southern California Cancer Center Support Grant
  NCI · Dec 1, 1996 – Nov 30, 2026 · Role: Principal Investigator
• COMPARING MODELS OF COUNSELING FOR BRCA1/2 TESTING
  NIH · R01HG001846 · Sep 30, 1994 – Aug 31, 2002 · Role: Co-Principal Investigator
• COMPARING MODELS OF PRETEST EDUCATION FOR BRCA1 TESTING
  NIH · R01MH054435 · Sep 30, 1994 – Aug 31, 1998 · Role: Principal Investigator
• COUNSELING WOMEN AT RISK FOR BREAST CANCER
  NIH · R01CA063605 · Sep 30, 1993 – Jul 31, 1998 · Role: Principal Investigator
• BIOBEHAVIORAL LUNG CANCER PREVENTION PROGRAM
  NIH · R01CA063562 · Sep 10, 1993 – May 31, 2004 · Role: Principal Investigator
• IMPROVING ADHERENCE IN WOMEN AT RISK FOR BREAST CANCER
  NIH · R01CA057767 · Sep 30, 1992 – Feb 28, 1998 · Role: Principal Investigator
• PREVENTIVE ONCOLOGY ACADEMIC AWARD
  NIH · K07CA001604 · Jul 1, 1991 – Jun 30, 1996 · Role: Principal Investigator
• University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)
  NIH · P30CA014089 · Apr 1, 1980 – Nov 30, 2026 · Role: Co-Principal Investigator
• Abramson Cancer Center Support Grant
  NIH · P30CA016520 · Nov 30, 2027 · Role: Co-Principal Investigator

• Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer risk. Breast Cancer Res Treat. 2026 Jul 10; 218(1).. View in PubMed
• Faster CYP2A6 increases COPD and lung cancer risk by increasing smoking quantity: a mediated mendelian randomization and observational mediation study. Respir Res. 2026 Jun 01.. View in PubMed
• Secondary Lung Cancer among Survivors of Adolescent and Young Adult Cancer: A Population-Based Study. Cancer Epidemiol Biomarkers Prev. 2025 Sep 02; 34(9):1618-1626.. View in PubMed
• A multi-site study examining the tobacco withdrawal trajectory in people with tobacco and cannabis co-use. Drug Alcohol Depend. 2025 Sep 01; 274:112778.. View in PubMed
• MammaTrace – a cell-free DNA methylation plasma only assay for minimal residual disease detection in breast cancer patients. medRxiv. 2025 May 21.. View in PubMed
• Sex dependent genetic architecture of biochemically verified tobacco use. Psychiatry Res. 2025 Jun; 348:116465.. View in PubMed
• Impact of Structural Racism and Social Determinants of Health on Disparities in Breast Cancer Mortality. Cancer Res. 2024 12 02; 84(23):3924-3935.. View in PubMed
• A structural MRI marker predicts individual differences in impulsivity and classifies patients with behavioral-variant frontotemporal dementia from matched controls. bioRxiv. 2024 Sep 16.. View in PubMed
• Fine-mapping the CYP2A6 regional association with nicotine metabolism among African American smokers. Mol Psychiatry. 2025 Mar; 30(3):943-953.. View in PubMed
• Multivariate analysis of multimodal brain structure predicts individual differences in risk and intertemporal preference. bioRxiv. 2024 Jul 08.. View in PubMed
• Reduced cortical complexity in ventromedial prefrontal cortex is associated with a greater preference for risky and immediate rewards. Imaging Neurosci (Camb). 2024; 2.. View in PubMed
• Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome-Wide Investigation of Abnormal Dreams on Varenicline. Clin Pharmacol Ther. 2024 06; 115(6):1277-1281.. View in PubMed
• CYP2A6 associates with respiratory disease risk and younger age of diagnosis: a phenome-wide association Mendelian Randomization study. Hum Mol Genet. 2024 01 07; 33(2):198-210.. View in PubMed
• Brain and cortisol responses to smoking cues are linked in tobacco-smoking individuals. Addict Biol. 2023 12; 28(12):e13338.. View in PubMed
• Less cortical complexity in ventromedial prefrontal cortex is associated with a greater preference for risky and immediate rewards. bioRxiv. 2023 Sep 13.. View in PubMed
• Influence of CYP2A6 Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success. Nicotine Tob Res. 2023 05 22; 25(6):1207-1211.. View in PubMed
• Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy. BMC Med Res Methodol. 2023 04 29; 23(1):107.. View in PubMed
• Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels. J Genet Couns. 2023 06; 32(3):706-716.. View in PubMed
• An fMRI-Based Brain Marker of Individual Differences in Delay Discounting. J Neurosci. 2023 03 01; 43(9):1600-1613.. View in PubMed
• Willingness to Use Commercial Nicotine Gums, Lozenges, and Gummies Among Nontobacco Using Adolescents in Southern California. J Adolesc Health. 2023 02; 72(2):277-286.. View in PubMed
• Development of Machine Learning Algorithms Incorporating Electronic Health Record Data, Patient-Reported Outcomes, or Both to Predict Mortality for Outpatients With Cancer. JCO Clin Cancer Inform. 2022 12; 6:e2200073.. View in PubMed
• A neural signature of the vividness of prospective thought is modulated by temporal proximity during intertemporal decision making. Proc Natl Acad Sci U S A. 2022 11; 119(44):e2214072119.. View in PubMed
• Differences in intention to use flavored oral nicotine products among young adult e-cigarette users and non-users. Prev Med Rep. 2022 Dec; 30:102027.. View in PubMed
• Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients. Ann Surg Oncol. 2023 Feb; 30(2):1017-1025.. View in PubMed
• Leadership Diversity and Development in the Nation’s Cancer Centers. J Natl Cancer Inst. 2022 09 09; 114(9):1214-1221.. View in PubMed
• Young adults’ beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping. Exp Clin Psychopharmacol. 2023 Apr; 31(2):455-463.. View in PubMed
• Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes. Mol Genet Genomic Med. 2022 10; 10(10):e2031.. View in PubMed
• Assessing the Coverage of US Cancer Center Primary Catchment Areas. Cancer Epidemiol Biomarkers Prev. 2022 05 04; 31(5):955-964.. View in PubMed
• Differences in Young Adults’ Perceptions of and Willingness to Use Nicotine Pouches by Tobacco Use Status. Int J Environ Res Public Health. 2022 02 25; 19(5).. View in PubMed
• Accuracy and applications of sequencing and genotyping approaches for CYP2A6 and homologous genes. Pharmacogenet Genomics. 2022 06 01; 32(4):159-172.. View in PubMed
• Examining the role of mitochondrial genetic variation in nicotine dependence. Psychiatry Res. 2022 04; 310:114452.. View in PubMed
• Balfour et al. Respond. Am J Public Health. 2022 01; 112(1):e2-e3.. View in PubMed
• Balfour et al. Respond. Am J Public Health. 2022 01; 112(1):e5-e6.. View in PubMed
• Asian Ethnic Subgroup Disparities in Delays of Surgical Treatment for Breast Cancer. JNCI Cancer Spectr. 2022 02; 6(1).. View in PubMed
• Analyses of nicotine metabolism biomarker genetics stratified by sex in African and European Americans. Sci Rep. 2021 10 01; 11(1):19572.. View in PubMed
• Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomes. Clin Transl Sci. 2022 01; 15(1):204-220.. View in PubMed
• A Genome-Wide Association Study of Nausea Incidence in Varenicline-Treated Cigarette Smokers. Nicotine Tob Res. 2021 08 29; 23(10):1805-1809.. View in PubMed
• Balancing Consideration of the Risks and Benefits of E-Cigarettes. Am J Public Health. 2021 09; 111(9):1661-1672.. View in PubMed
• Subjective value, not a gridlike code, describes neural activity in ventromedial prefrontal cortex during value-based decision-making. Neuroimage. 2021 08 15; 237:118159.. View in PubMed
• Nicotine metabolite ratio: Comparison of the three urinary versions to the plasma version and nicotine clearance in three clinical studies. Drug Alcohol Depend. 2021 06 01; 223:108708.. View in PubMed
• Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder. Am J Addict. 2021 07; 30(4):382-388.. View in PubMed
• Evidence for racial/ethnic disparities in emergency department visits following breast cancer surgery among women in California: a population-based study. Breast Cancer Res Treat. 2021 Jun; 187(3):831-841.. View in PubMed
• Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations. Clin Pharmacol Ther. 2021 10; 110(4):975-985.. View in PubMed
• Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer. 2021 04 15; 127(8):1275-1285.. View in PubMed
• Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer. Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2126-2133.. View in PubMed
• Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV. Psychol Addict Behav. 2021 Nov; 35(7):788-796.. View in PubMed
• Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse. Nicotine Tob Res. 2020 07 16; 22(8):1277-1284.. View in PubMed
• Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. Nicotine Tob Res. 2020 05 26; 22(6):900-909.. View in PubMed
• Brain Marker Links Stress and Nicotine Abstinence. Nicotine Tob Res. 2020 05 26; 22(6):885-891.. View in PubMed
• Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial. Drug Alcohol Depend. 2020 05 01; 210:107967.. View in PubMed
• Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent. Mol Psychiatry. 2021 06; 26(6):2212-2223.. View in PubMed
• The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions. Cancer Prev Res (Phila). 2020 03; 13(3):261-272.. View in PubMed
• Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain. Drug Alcohol Depend. 2020 04 01; 209:107901.. View in PubMed
• Impact of early nausea on varenicline adherence and smoking cessation. Addiction. 2020 01; 115(1):134-144.. View in PubMed
• Differences in the rate of nicotine metabolism among smokers with and without HIV. AIDS. 2019 05 01; 33(6):1083-1088.. View in PubMed
• Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity. Addict Biol. 2020 01; 25(1):e12741.. View in PubMed
• Neural cue reactivity during acute abstinence predicts short-term smoking relapse. Addict Biol. 2020 03; 25(2):e12733.. View in PubMed
• Evaluating the temporal relationships between withdrawal symptoms and smoking relapse. Psychol Addict Behav. 2019 Mar; 33(2):105-116.. View in PubMed
• Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial. Drug Alcohol Depend. 2019 01 01; 194:244-251.. View in PubMed
• Got chocolate? Bilateral prefrontal cortex stimulation augments chocolate consumption. Appetite. 2018 12 01; 131:28-35.. View in PubMed
• Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial. JAMA Netw Open. 2018 08; 1(4):e181346.. View in PubMed
• Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes. Drug Alcohol Depend. 2018 09 01; 190:72-81.. View in PubMed
• A Comparison of Direct and Indirect Analytical Approaches to Measuring Total Nicotine Equivalents in Urine. Cancer Epidemiol Biomarkers Prev. 2018 08; 27(8):882-891.. View in PubMed
• What a medical school chair wants from the dean. J Healthc Leadersh. 2018; 10:33-44.. View in PubMed
• Leadership Development in Medicine. N Engl J Med. 2018 May 17; 378(20):1862-1863.. View in PubMed
• Transcranial direct current brain stimulation decreases impulsivity in ADHD. Brain Stimul. 2018 Sep – Oct; 11(5):974-981.. View in PubMed
• Amygdala Functional and Structural Connectivity Predicts Individual Risk Tolerance. Neuron. 2018 04 18; 98(2):394-404.e4.. View in PubMed
• Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. Pharmacogenet Genomics. 2018 Jan; 28(1):7-16.. View in PubMed
• Improvement of the association between self-reported pill count and varenicline levels following exclusion of participants with misreported pill count: A commentary on Peng et al. (2017). Addict Behav. 2018 04; 79:14-16.. View in PubMed
• Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences. Addiction. 2018 03; 113(3):509-523.. View in PubMed
• Measures and predictors of varenicline adherence in the treatment of nicotine dependence. Addict Behav. 2017 12; 75:122-129.. View in PubMed
• No Effect of Commercial Cognitive Training on Brain Activity, Choice Behavior, or Cognitive Performance. J Neurosci. 2017 08 02; 37(31):7390-7402.. View in PubMed
• Can brain games help smokers quit?: Results of a randomized clinical trial. Drug Alcohol Depend. 2016 Nov 01; 168:112-118.. View in PubMed
• Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial. Am J Addict. 2016 06; 25(4):291-6.. View in PubMed
• Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. Pharmacol Biochem Behav. 2016 09; 148:1-7.. View in PubMed
• Nicotine withdrawal alters neural responses to psychosocial stress. Psychopharmacology (Berl). 2016 07; 233(13):2459-67.. View in PubMed
• Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment? J Smok Cessat. 2017 Jun; 12(2):63-70. Ashare RL, Lerman C , Tyndale RF, Hawk LW, George TP, Cinciripini P, Schnoll R . View in PubMed
• Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio. J Neuroimmune Pharmacol. 2016 09; 11(3):471-83.. View in PubMed
• Translational Research on Nicotine Dependence. Curr Top Behav Neurosci. 2016; 28:121-50.. View in PubMed
• Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate. Biol Psychiatry. 2016 08 01; 80(3):190-7.. View in PubMed
• RNA sequencing of transcriptomes in human brain regions: protein-coding and non-coding RNAs, isoforms and alleles. BMC Genomics. 2015 Nov 23; 16:990.. View in PubMed
• Transcranial Direct Current Brain Stimulation Increases Ability to Resist Smoking. Brain Stimul. 2016 Mar-Apr; 9(2):191-6.. View in PubMed
• Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. J Nucl Med. 2015 Nov; 56(11):1724-9.. View in PubMed
• Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. PLoS One. 2015; 10(7):e0126113.. View in PubMed
• The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio. Nicotine Tob Res. 2016 Apr; 18(4):491-5.. View in PubMed
• Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. PLoS One. 2015; 10(5):e0128109.. View in PubMed
• Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation. Cancer Epidemiol Biomarkers Prev. 2015 Aug; 24(8):1239-46.. View in PubMed
• Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence. Nicotine Tob Res. 2016 Jan; 18(1):74-8.. View in PubMed
• Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers. Nicotine Tob Res. 2015 Dec; 17(12):1505-9.. View in PubMed
• Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. Lancet Respir Med. 2015 Feb; 3(2):131-138.. View in PubMed
• Working memory-related neural activity predicts future smoking relapse. Neuropsychopharmacology. 2015 May; 40(6):1311-20.. View in PubMed
• Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiol Biomarkers Prev. 2014 Sep; 23(9):1773-82.. View in PubMed
• Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. JAMA Psychiatry. 2014 May; 71(5):523-30.. View in PubMed
• Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome. Drug Alcohol Depend. 2014 May 01; 138:109-17.. View in PubMed
• An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. Psychopharmacology (Berl). 2014 Jan; 231(1):1-11.. View in PubMed
• Applying Quantitative Approaches to the Formative Evaluation of Antismoking Campaign Messages. Soc Mar Q. 2013 Dec; 19(4):242-264.. View in PubMed
• Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction. 2013 Dec; 108(12):2202-11.. View in PubMed
• Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study. Drug Alcohol Depend. 2013 Dec 15; 133(3):852-6.. View in PubMed
• Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. Mol Psychiatry. 2014 Jul; 19(7):801-10.. View in PubMed
• Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications. Addiction. 2013 Nov; 108(11):1962-8.. View in PubMed

• Leventhal, Adam
• Unger, Jennifer
• Barrington-Trimis, Jessica
• Sussman, Steven
• Pang, Raina
• Kirkpatrick, Matthew